We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 7,203 results
  1. miRNA-146a-5p Inhibits Hypoxia-Induced Myocardial Fibrosis Through EndMT

    Cardiac Vascular disease particularly myocardial infarction (MI) is a threat to health worldwide. microRNAs (miRNAs) have been shown to regulate...

    Yan Wang, Jie Yu, ... Longjun Li in Cardiovascular Toxicology
    Article 05 January 2024
  2. Biomarkers of Myocardial Fibrosis in Diabetes, Echocardiography, and Magnetic Resonance Imaging

    Diabetes mellitus (DM) is associated with cardiomyopathy. Cardiomyopathy in DM can be from ischemic heart disease or related purely to DM-related...
    Per Lav Madsen in Biomarkers in Diabetes
    Reference work entry 2023
  3. CHI3L1 promotes myocardial fibrosis via regulating lncRNA TUG1/miR-495-3p/ETS1 axis

    Abnormal levels of CHI3L1 and lnc TUG1 are often associated with myocardial fibrosis, and their specific expressions may be closely related to the...

    Yunpeng Sun, Xue Shan, ... Dashi Ma in Apoptosis
    Article 07 June 2023
  4. Genetics of myocardial interstitial fibrosis in the human heart and association with disease

    Myocardial interstitial fibrosis is associated with cardiovascular disease and adverse prognosis. Here, to investigate the biological pathways that...

    Victor Nauffal, Paolo Di Achille, ... Steven A. Lubitz in Nature Genetics
    Article 20 April 2023
  5. Inhibition of tartrate-resistant acid phosphatase 5 can prevent cardiac fibrosis after myocardial infarction

    Background

    Myocardial infarction (MI) leads to enhanced activity of cardiac fibroblasts (CFs) and abnormal deposition of extracellular matrix...

    Shujun Yang, Liying Pei, ... Tong Wang in Molecular Medicine
    Article Open access 15 June 2024
  6. HTRA1-driven detachment of type I collagen from endoplasmic reticulum contributes to myocardial fibrosis in dilated cardiomyopathy

    Background

    The aberrant secretion and excessive deposition of type I collagen (Col1) are important factors in the pathogenesis of myocardial fibrosis...

    Hongjie Shi, Ming Yuan, ... **** Liu in Journal of Translational Medicine
    Article Open access 22 March 2024
  7. PD-1 Inhibitor Aggravate Irradiation-Induced Myocardial Fibrosis by Regulating TGF-β1/Smads Signaling Pathway via GSDMD-Mediated Pyroptosis

    Cancer therapy has entered a new era with the use of programmed cell death protein 1 (PD-1) immune checkpoint inhibitors. When combined with thoracic...

    Bibo Wu, Shasha Zhao, ... Shengfa Su in Inflammation
    Article 21 May 2024
  8. Macrophages promote the transition from myocardial ischemia reperfusion injury to cardiac fibrosis in mice through GMCSF/CCL2/CCR2 and phenotype switching

    Following acute myocardial ischemia reperfusion (MIR), macrophages infiltrate damaged cardiac tissue and alter their polarization phenotype to...

    Shi-chun Shen, Jie Xu, ... Li-kun Ma in Acta Pharmacologica Sinica
    Article 15 January 2024
  9. Identification of diagnostic model in heart failure with myocardial fibrosis and conduction block by integrated gene co-expression network analysis

    Background

    Despite the advancements in heart failure(HF) research, the early diagnosis of HF continues to be a challenging issue in clinical practice....

    Yonghua Yuan, Yiwei Niu, ... Sun Chen in BMC Medical Genomics
    Article Open access 14 February 2024
  10. USP38 exacerbates atrial inflammation, fibrosis, and susceptibility to atrial fibrillation after myocardial infarction in mice

    Background

    Inflammation plays an important role in the pathogenesis of atrial fibrillation (AF) after myocardial infarction (MI). The role of USP38, a...

    Yang Gong, Tingting Yu, ... He Huang in Molecular Medicine
    Article Open access 12 November 2023
  11. IL-37 ameliorates myocardial fibrosis by regulating mtDNA-enriched vesicle release in diabetic cardiomyopathy mice

    Background

    Diabetic cardiomyopathy (DCM), a serious complication of diabetes, leads to structural and functional abnormalities of the heart and...

    Qingyu Huang, Tongqing Chen, ... Bangwei Wu in Journal of Translational Medicine
    Article Open access 24 May 2024
  12. Upregulation of glycolytic enzyme PFKFB3 by deubiquitinase OTUD4 promotes cardiac fibrosis post myocardial infarction

    Abstract

    Metabolic dysregulations have emerged as a major mediator of cardiovascular disorders and fibrotic diseases. Metabolic reprogramming...

    Feizuo Wang, **aojian Yin, ... Jia Li in Journal of Molecular Medicine
    Article Open access 10 May 2023
  13. Biomarkers of Myocardial Fibrosis in Diabetes, Echocardiography, and Magnetic Resonance Imaging

    Diabetes mellitus (DM) is associated with cardiomyopathy. Cardiomyopathy in DM can be from ischemic heart disease or related purely to DM-related...
    Per Lav Madsen in Biomarkers in Diabetes
    Living reference work entry 2022
  14. Radiotherapy-induced diffuse myocardial fibrosis in early-stage breast cancer patients – multimodality imaging study with six-year follow-up

    Background

    Breast radiotherapy (RT) induces diffuse myocardial changes, which may increase the incidence of heart failure with preserved ejection...

    Mikko Moisander, Tanja Skyttä, ... Suvi Tuohinen in Radiation Oncology
    Article Open access 26 July 2023
  15. Klotho improves cardiac fibrosis, inflammatory cytokines, ferroptosis, and oxidative stress in mice with myocardial infarction

    The anti-aging protein Klotho has been associated with cardiovascular health protection. Nevertheless, the protective mechanism remains unknown. The...

    Kai WANG, Zhongming LI, ... Di XU in Journal of Physiology and Biochemistry
    Article 26 January 2023
  16. Inhibition of Pyruvate kinase M2 (PKM2) by shikonin attenuates isoproterenol-induced acute myocardial infarction via reduction in inflammation, hypoxia, apoptosis, and fibrosis

    Myocardial infarction (MI) is a major cause of mortality and disability globally. MI results from acute or chronic myocardial ischemia characterized...

    Mohd Rihan, Shyam Sunder Sharma in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 29 June 2023
  17. Fibrosis

    Reference work entry 2024
  18. Gut bacterial metabolite Urolithin A inhibits myocardial fibrosis through activation of Nrf2 pathway in vitro and in vivo

    Background

    Myocardial fibrosis after myocardial infarction (MI) is one of the leading causes of cardiovascular diseases. Cardiac fibroblasts (CFs) are...

    Pengfei Chen, Junyu Pei, ... **nqun Hu in Molecular Medicine
    Article Open access 08 February 2022
  19. Indoxyl Sulfate Activates NLRP3 Inflammasome to Induce Cardiac Contractile Dysfunction Accompanied by Myocardial Fibrosis and Hypertrophy

    In patients with chronic kidney diseases (CKD), high serum indoxyl sulfate (IS) levels correlate with cardiac fibrosis and hypertrophy and thus a...

    Kazutoshi Yamaguchi, Maimaiti Yisireyili, ... Kyosuke Takeshita in Cardiovascular Toxicology
    Article 28 January 2022
  20. Myocardial fibrosis reversion via rhACE2-electrospun fibrous patch for ventricular remodeling prevention

    Myocardial fibrosis and ventricular remodeling were the key pathology factors causing undesirable consequence after myocardial infarction. However,...

    Ze** Qiu, **gwen Zhao, ... Wei ** in npj Regenerative Medicine
    Article Open access 10 August 2021
Did you find what you were looking for? Share feedback.